https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/uk-cancer-patient-joins-trial-for-worlds-first-skin-cancer-vaccine/109649348
0
0
4/27/24 at 12:13pm
Organization
The Times of India
Author
ET HealthWorld
The new Phase 3 clinical trial, being led by UCLH, is evaluating the combination of mRNA-4157 (V940) and Keytruda (pembrolizumab) versus a current standard of care (pembrolizumab) as a risk-reducing treatment option for patients with resected high-risk, stag…
Create an account
or login to join the discussion